Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04090710
Title SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer (CYTOSHRINK)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ontario Clinical Oncology Group (OCOG)
Age Groups: senior | adult | child
Covered Countries CAN | AUS

Facility Status City State Zip Country Details
Peter MacCallum Cancer Centre Melbourne 3000 Australia Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Juravinski Cancer Centre Hamilton Ontario Canada Details
Grand River Regional Cancer Centre Kitchener Ontario N2G1G3 Canada Details
London Regional Cancer Centre London Ontario N2G1G3 Canada Details
The Ottawa Regional Cancer Centre Ottawa Ontario K1H8L6 Canada Details
Sunnybrook Health Sciences Centre- Odette Cancer Centre Toronto Ontario M4N3M5 Canada Details
*Shaded cells indicate that there was no data available from for the field